載入...
New Agents Targeting Angiogenesis in Glioblastoma
Glioblastoma is the most common malignant glioma in adults, and despite recent advances in standard treatment, the prognosis still remains dismal, with a median survival of 15 months. The incorporation of bevacizumab in the standard treatment of relapsed glioblastoma has been a significant step towa...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Publishing Corporation
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263613/ https://ncbi.nlm.nih.gov/pubmed/22295207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/878912 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|